BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

Navigation und Service

Citalopram and risk of QT prolongation - Final SmPC and PL wording agreed by the PhVWP in October 2011

Citalopram - SmPC und PL Texte

Citalopram and risk of QT prolongation - Final SmPC and PL wording agreed by the PhVWP in October 2011 PDF, 48KB, barrierefrei ⁄ barrierearm